Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study Of Diflucan In Children With Ringworm Of The Scalp

ClinicalTrials.gov ID: NCT00645242

Public ClinicalTrials.gov record NCT00645242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 8:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Multicenter Trial Of Diflucan (Fluconazole) For 6 Weeks Given Once Daily To Pediatric Patients With Tinea Capitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.

Study identification

NCT ID
NCT00645242
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
185 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2002 (Type not available)
Primary completion
Not listed
Completion
Mar 2003 (Actual)
Last update posted
Jul 16, 2021

2002 – 2003

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Pfizer Investigational Site Montgomery Alabama 36116 —
Pfizer Investigational Site Little Rock Arkansas 72205 —
Pfizer Investigational Site San Diego California 92123 —
Pfizer Investigational Site Miami Florida 33156-7712 —
Pfizer Investigational Site Miami Florida 33156 —
Pfizer Investigational Site Martinez Georgia 30907 —
Pfizer Investigational Site Chicago Illinois 60630 —
Pfizer Investigational Site Evanston Illinois 60202 —
Pfizer Investigational Site Gretna Louisiana 70056 —
Pfizer Investigational Site New Orleans Louisiana 70119 —
Pfizer Investigational Site Shreveport Louisiana 71105 —
Pfizer Investigational Site Detroit Michigan 48201 —
Pfizer Investigational Site Fridley Minnesota 55432 —
Pfizer Investigational Site Bridgeton Missouri 63044 —
Pfizer Investigational Site Brooklyn New York 11203-2098 —
Pfizer Investigational Site Garner North Carolina 27529 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Cleveland Ohio 44106 —
Pfizer Investigational Site Columbus Ohio 43205 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Knoxville Tennessee 37927 —
Pfizer Investigational Site Murfreesboro Tennessee 37130 —
Pfizer Investigational Site Nashville Tennessee 37215 —
Pfizer Investigational Site Houston Texas 77056 —
Pfizer Investigational Site San Antonio Texas 78205 —
Pfizer Investigational Site San Antonio Texas 78224 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00645242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00645242 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →